221 related articles for article (PubMed ID: 12396018)
1. Therapeutic inhibition of the early phase of complement activation.
Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
[TBL] [Abstract][Full Text] [Related]
2. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
3. Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
Skliris A; Happonen KE; Terpos E; Labropoulou V; Børset M; Heinegård D; Blom AM; Theocharis AD
Eur J Immunol; 2011 Feb; 41(2):437-49. PubMed ID: 21268013
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfates.
Bureeva S; Andia-Pravdivy J; Symon A; Bichucher A; Moskaleva V; Popenko V; Shpak A; Shvets V; Kozlov L; Kaplun A
Bioorg Med Chem; 2007 May; 15(10):3489-98. PubMed ID: 17383882
[TBL] [Abstract][Full Text] [Related]
5. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
[TBL] [Abstract][Full Text] [Related]
6. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
[TBL] [Abstract][Full Text] [Related]
7. Interaction of C1q and mannan-binding lectin with viruses.
Thielens NM; Tacnet-Delorme P; Arlaud GJ
Immunobiology; 2002 Sep; 205(4-5):563-74. PubMed ID: 12396016
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the humoral pattern recognition molecule PTX3 with the complement system.
Doni A; Garlanda C; Bottazzi B; Meri S; Garred P; Mantovani A
Immunobiology; 2012 Nov; 217(11):1122-8. PubMed ID: 22964239
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
[TBL] [Abstract][Full Text] [Related]
11. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency.
Roos A; Garred P; Wildenberg ME; Lynch NJ; Munoz JR; Zuiverloon TC; Bouwman LH; Schlagwein N; Fallaux van den Houten FC; Faber-Krol MC; Madsen HO; Schwaeble WJ; Matsushita M; Fujita T; Daha MR
Eur J Immunol; 2004 Sep; 34(9):2589-98. PubMed ID: 15307191
[TBL] [Abstract][Full Text] [Related]
12. Clionasterol: a potent inhibitor of complement component C1.
Cerqueira F; Watanadilok R; Sonchaeng P; Kijjoa A; Pinto M; Quarles van Ufford H; Kroes B; Beukelman C; Nascimento MS
Planta Med; 2003 Feb; 69(2):174-6. PubMed ID: 12624828
[TBL] [Abstract][Full Text] [Related]
13. A novel series of potent and selective small molecule inhibitors of the complement component C1s.
Subasinghe NL; Ali F; Illig CR; Jonathan Rudolph M; Klein S; Khalil E; Soll RM; Bone RF; Spurlino JC; DesJarlais RL; Crysler CS; Cummings MD; Morris PE; Kilpatrick JM; Sudhakara Babu Y
Bioorg Med Chem Lett; 2004 Jun; 14(12):3043-7. PubMed ID: 15149641
[TBL] [Abstract][Full Text] [Related]
14. Complement activation and disease: protective effects of hyperbilirubinaemia.
Basiglio CL; Arriaga SM; Pelusa F; Almará AM; Kapitulnik J; Mottino AD
Clin Sci (Lond); 2009 Oct; 118(2):99-113. PubMed ID: 19807696
[TBL] [Abstract][Full Text] [Related]
15. Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin.
Matsushita M; Matsushita A; Endo Y; Nakata M; Kojima N; Mizuochi T; Fujita T
Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10127-31. PubMed ID: 15218103
[TBL] [Abstract][Full Text] [Related]
16. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.
Brown JS; Hussell T; Gilliland SM; Holden DW; Paton JC; Ehrenstein MR; Walport MJ; Botto M
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16969-74. PubMed ID: 12477926
[TBL] [Abstract][Full Text] [Related]
17. New perspectives on mannan-binding lectin-mediated complement activation.
Degn SE; Thiel S; Jensenius JC
Immunobiology; 2007; 212(4-5):301-11. PubMed ID: 17544815
[TBL] [Abstract][Full Text] [Related]
18. [Effect of medicinal preparations on the complement: inhibition of subcomponent C1q binding to a target].
Bichucher AM; Kozlov LV
Eksp Klin Farmakol; 2007; 70(6):25-8. PubMed ID: 18318191
[TBL] [Abstract][Full Text] [Related]
19. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury.
Walsh MC; Bourcier T; Takahashi K; Shi L; Busche MN; Rother RP; Solomon SD; Ezekowitz RA; Stahl GL
J Immunol; 2005 Jul; 175(1):541-6. PubMed ID: 15972690
[TBL] [Abstract][Full Text] [Related]
20. Hemolytic assay for the measurement of functional human mannose-binding lectin: a modification to avoid interference from classical pathway activation.
Herpers BL; de Jong BA; Dekker B; Aerts PC; van Dijk H; Rijkers GT; van Velzen-Blad H
J Immunol Methods; 2009 Mar; 343(1):61-3. PubMed ID: 19171151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
